Pursuant To The APA, LianBio Development Will Receive A Payment Of $25M; Eligible To Receive A Sales Milestone Payment Of $5M Within 60 Days After The End Of The First Calendar Year If Net Sales Of The Licensed Products In China Exceed $20M
- SEC Filing